|
NME3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02806652080289E-13 |
| Normal-vs-Stage2 |
5.244700E-03 |
| Normal-vs-Stage3 |
4.756800E-04 |
| Normal-vs-Stage4 |
2.180500E-02 |
| Stage1-vs-Stage2 |
1.034040E-01 |
| Stage1-vs-Stage3 |
7.612200E-01 |
| Stage1-vs-Stage4 |
8.818400E-02 |
| Stage2-vs-Stage3 |
3.556000E-01 |
| Stage2-vs-Stage4 |
8.680000E-01 |
| Stage3-vs-Stage4 |
3.852200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.47730000000535E-05 |
| Normal-vs-Asian |
2.157800E-01 |
| Caucasian-vs-AfricanAmerican |
9.199800E-02 |
| Caucasian-vs-Asian |
7.898000E-01 |
| AfricanAmerican-vs-Asian |
7.623400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.360000E-04 |
| Male-vs-Female |
3.075000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.779940E-04 |
| Normal-vs-Extreme_Weight |
1.65600866353088E-12 |
| Normal-vs-Obese |
8.47319999719431E-08 |
| Normal-vs-Extreme_Obese |
2.290000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.474800E-01 |
| Normal_Weight-vs-Obese |
8.376400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.047800E-01 |
| Extreme_Weight-vs-Obese |
2.555800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.367000E-01 |
| Obese-vs-Extreme_Obese |
9.921200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.616000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.63498120492523E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(81-100Yrs) |
1.662380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.461200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.100400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.177000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.162000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.341800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.366060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.780900E-03 |
| Normal-VS-KIRP CIMP |
6.577200E-01 |
| Normal-VS-Unclassified PRCC |
4.49650000000634E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.35729999461986E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.29439999999137E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.946840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.237400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.083200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.279900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.97590000034143E-07 |
| Normal-vs-N1 |
7.479000E-03 |
| Normal-vs-N2 |
6.024800E-01 |
| N0-vs-N1 |
3.873200E-01 |
| N0-vs-N2 |
2.667200E-01 |
| N1-vs-N2 |
5.000000E-01 |
|
|
